Apr 18 |
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
|
Apr 8 |
Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
|
Mar 22 |
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
|
Mar 22 |
Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
|
Mar 20 |
Puma Biotech cleared to trial Takeda-partnered breast cancer therapy in U.S.
|
Mar 20 |
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
|
Mar 18 |
Puma Biotechnology dips after dismissal of its suit was granted by a federal judge
|
Mar 5 |
Puma Biotechnology, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 5 |
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
|
Mar 4 |
J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
|